welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
study id #: NCT03067831
condition: Duchenne Muscular Dystrophy
status: recruiting
purpose:This study is single arm, single center trial to study the safety and efficacy of bone marrow-derived autologous specific populations of stem cells and mesenchymal stem cells for the treatment of Duchenne Muscular Dystrophy (DMD).
intervention: Stem Cells
mechanism of action: Stem cell therapy to promote cellular regeneration
results: https://clinicaltrials.gov/ct2/show/results/NCT03067831
last updated: March 25, 2020
rareRelated
-
CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic CarriersThis is an investigation of the efficacy...
-
Treatment Effect of Tamoxifen on Patients With DMDDuchenne muscular dystrophy (DMD) is a p...
-
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, ran...Background: Duchenne muscular dystrophy...
-
Microdystrophin Gene Transfer Study in Adolescents and Children With DMDThis is a controlled, open-label, single...
-
Extension Study of ACE-031 in Subjects With Duchenne Muscular DystrophyTo evaluate the long-term safety and tol...
-
UCLA’s Duchenne Muscular Dystrophy Research Funded by a Stem Cell AgencyScientists at the UCLA Eli and Edythe Br...
-
Safety Study of Flavocoxid in Duchenne Muscular DystrophyObjective of this study is to evaluate s...
-
Catabasis Pharmaceuticals Announces Publication Of Phase 1 Clinical Results Of Edasalonexent (CAT-1004) In Duchenne ...Catabasis Pharmaceuticals, Inc., a clini...
-
AbCellera is enabling the translation of laboratory research to clinical application for fibrosis associated with co...Duchenne muscular dystrophy (DMD) is one...
-
Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and TherapyDuchenne muscular dystrophy (DMD) is an ...